IL33 and melanoma: To investigate whether the C3 modulatory effects observed in MCs treated with RPMI-7951 melanoma-conditioned media could be attributed to the TME cytokines TGF-β, IL-1β, and IL-33 (expression of the latter induced in MCs by melanoma cell supernatants), we blocked their activities using neutralizing antibodies or isotype controls.